Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/11533711

Download in:

View as

General Info

PMID
11533711